Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2025-12-16 @ 8:04 PM
Study NCT ID:
NCT00002994
Status:
None
Last Update Posted:
2016-06-28 00:00:00
First Post:
1999-11-01 00:00:00
Brief Title:
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
Sponsor:
Organization:
Alliance for Clinical Trials in Oncology
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
355
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: